Correction to: Phosphodiesterase 10A Inhibition Leads to Brain Region-Specific Recovery Based on Stroke Type.

Birjandi, Shirin Z; Abduljawad, Nora; Nair, Shyama; Dehghani, Morteza; Suzuki, Kazunori; Kimura, Haruhide; Carmichael, S Thomas

Birjandi, Shirin Z; Abduljawad, Nora; Nair, Shyama; Dehghani, Morteza; Suzuki, Kazunori; Kimura, Haruhide; Carmichael, S Thomas.

Affiliation

Birjandi SZ; Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
Abduljawad N; Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
Nair S; Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA.
Dehghani M; Departments of Psychology and of Computer Science, University of Southern California, Los Angeles, CA, USA.
Suzuki K; Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
Kimura H; Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
Carmichael ST; Departments of Neurology and of Neurobiology, David Geffen, School of Medicine at UCLA, Los Angeles, CA, USA. scarmich@g.ucla.edu.

Transl Stroke Res ; 12(4): 691, 2021 Aug.

Article de En | MEDLINE | ID: mdl-33123953

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Transl Stroke Res Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google